Hojnik, M.; Kenda Šuster, N.; Smrkolj, Š.; Frković Grazio, S.; Verdenik, I.; Rižner, T.L.
AKR1C3 Is Associated with Better Survival of Patients with Endometrial Carcinomas. J. Clin. Med. 2020, 9, 4105.
https://doi.org/10.3390/jcm9124105
AMA Style
Hojnik M, Kenda Šuster N, Smrkolj Š, Frković Grazio S, Verdenik I, Rižner TL.
AKR1C3 Is Associated with Better Survival of Patients with Endometrial Carcinomas. Journal of Clinical Medicine. 2020; 9(12):4105.
https://doi.org/10.3390/jcm9124105
Chicago/Turabian Style
Hojnik, Marko, Nataša Kenda Šuster, Špela Smrkolj, Snježana Frković Grazio, Ivan Verdenik, and Tea Lanišnik Rižner.
2020. "AKR1C3 Is Associated with Better Survival of Patients with Endometrial Carcinomas" Journal of Clinical Medicine 9, no. 12: 4105.
https://doi.org/10.3390/jcm9124105
APA Style
Hojnik, M., Kenda Šuster, N., Smrkolj, Š., Frković Grazio, S., Verdenik, I., & Rižner, T. L.
(2020). AKR1C3 Is Associated with Better Survival of Patients with Endometrial Carcinomas. Journal of Clinical Medicine, 9(12), 4105.
https://doi.org/10.3390/jcm9124105